Haruyuki Nishida

821 total citations
13 papers, 659 citations indexed

About

Haruyuki Nishida is a scholar working on Gastroenterology, Surgery and Molecular Biology. According to data from OpenAlex, Haruyuki Nishida has authored 13 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Gastroenterology, 9 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Haruyuki Nishida's work include Gastroesophageal reflux and treatments (11 papers), Helicobacter pylori-related gastroenterology studies (9 papers) and Ion Transport and Channel Regulation (4 papers). Haruyuki Nishida is often cited by papers focused on Gastroesophageal reflux and treatments (11 papers), Helicobacter pylori-related gastroenterology studies (9 papers) and Ion Transport and Channel Regulation (4 papers). Haruyuki Nishida collaborates with scholars based in Japan. Haruyuki Nishida's co-authors include Nobuhiro Inatomi, Yasunobu Hori, Masahiro Kajino, Jun Matsukawa, Keizo Hirase, Yasuyoshi Arikawa, Akio Imanishi, Toshiyuki Takeuchi, Yasuhiro Tsukimi and Terufumi Takagi and has published in prestigious journals such as Gastroenterology, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Haruyuki Nishida

12 papers receiving 641 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Haruyuki Nishida Japan	9	454	415	193	116	89	13	659
Yasunobu Hori Japan	8	415 0.9×	398 1.0×	172 0.9×	107 0.9×	87 1.0×	11	627
Masahiro Kajino Japan	14	429 0.9×	382 0.9×	177 0.9×	325 2.8×	220 2.5×	24	883
Keizo Hirase Japan	6	217 0.5×	200 0.5×	93 0.5×	98 0.8×	63 0.7×	7	359
Mohammed Hassan‐Alin Sweden	11	530 1.2×	558 1.3×	148 0.8×	26 0.2×	67 0.8×	18	819
Leif Rikner Sweden	8	396 0.9×	305 0.7×	79 0.4×	71 0.6×	84 0.9×	11	657
Reinhold Lühmann Germany	18	545 1.2×	539 1.3×	137 0.7×	11 0.1×	74 0.8×	35	800
Majid Vakily United States	13	263 0.6×	262 0.6×	44 0.2×	26 0.2×	49 0.6×	20	505
Yuuichi Sakurai Japan	10	807 1.8×	727 1.8×	343 1.8×	10 0.1×	39 0.4×	18	926
Ishizaki Japan	4	235 0.5×	215 0.5×	78 0.4×	13 0.1×	28 0.3×	7	421
Ernst Sturm Germany	11	125 0.3×	107 0.3×	52 0.3×	77 0.7×	126 1.4×	17	400

Countries citing papers authored by Haruyuki Nishida

Since Specialization

Citations

This map shows the geographic impact of Haruyuki Nishida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haruyuki Nishida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haruyuki Nishida more than expected).

Fields of papers citing papers by Haruyuki Nishida

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haruyuki Nishida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haruyuki Nishida. The network helps show where Haruyuki Nishida may publish in the future.

Co-authorship network of co-authors of Haruyuki Nishida

This figure shows the co-authorship network connecting the top 25 collaborators of Haruyuki Nishida. A scholar is included among the top collaborators of Haruyuki Nishida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haruyuki Nishida. Haruyuki Nishida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Matsukawa, Jun, Nobuhiro Inatomi, Haruyuki Nishida, & Yasuhiro Tsukimi. (2018). Pharmacological characteristics and clinical efficacies of a novel potassium-competitive acid blocker, vonoprazan fumarate. Folia Pharmacologica Japonica. 152(3). 104–110. 2 indexed citations

Nishida, Haruyuki, Ikuo Fujimori, Yasuyoshi Arikawa, et al.. (2017). Exploration of pyrrole derivatives to find an effective potassium-competitive acid blocker with moderately long-lasting suppression of gastric acid secretion. Bioorganic & Medicinal Chemistry. 25(13). 3447–3460. 8 indexed citations

Imaeda, Toshihiro, Koji Ono, Kazuo Nakai, et al.. (2017). Discovery, synthesis, and structure-activity relations of 3,4-dihydro-1H-spiro(naphthalene-2,2′-piperidin)-1-ones as potassium-competitive acid blockers. Bioorganic & Medicinal Chemistry. 25(14). 3719–3735. 10 indexed citations

Nishida, Haruyuki, Yasuyoshi Arikawa, Keizo Hirase, et al.. (2017). Identification of a novel fluoropyrrole derivative as a potassium-competitive acid blocker with long duration of action. Bioorganic & Medicinal Chemistry. 25(13). 3298–3314. 7 indexed citations

Otake, Kazuyoshi, Yuuichi Sakurai, Haruyuki Nishida, et al.. (2016). Characteristics of the Novel Potassium-Competitive Acid Blocker Vonoprazan Fumarate (TAK-438). Advances in Therapy. 33(7). 1140–1157. 71 indexed citations

Arikawa, Yasuyoshi, Atsushi Hasuoka, Haruyuki Nishida, et al.. (2015). Synthetic studies of five-membered heteroaromatic derivatives as potassium-competitive acid blockers (P-CABs). Bioorganic & Medicinal Chemistry Letters. 25(10). 2037–2040. 6 indexed citations

Nishida, Haruyuki, Atsushi Hasuoka, Yasuyoshi Arikawa, et al.. (2012). Discovery, synthesis, and biological evaluation of novel pyrrole derivatives as highly selective potassium-competitive acid blockers. Bioorganic & Medicinal Chemistry. 20(12). 3925–3938. 42 indexed citations

Arikawa, Yasuyoshi, Haruyuki Nishida, Osamu Kurasawa, et al.. (2012). Discovery of a Novel Pyrrole Derivative 1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine Fumarate (TAK-438) as a Potassium-Competitive Acid Blocker (P-CAB). Journal of Medicinal Chemistry. 55(9). 4446–4456. 128 indexed citations

Hori, Yasunobu, Jun Matsukawa, Toshiyuki Takeuchi, et al.. (2011). A Study Comparing the Antisecretory Effect of TAK-438, a Novel Potassium-Competitive Acid Blocker, with Lansoprazole in Animals. Journal of Pharmacology and Experimental Therapeutics. 337(3). 797–804. 124 indexed citations

10.

Matsukawa, Jun, Yasunobu Hori, Haruyuki Nishida, Masahiro Kajino, & Nobuhiro Inatomi. (2011). A comparative study on the modes of action of TAK-438, a novel potassium-competitive acid blocker, and lansoprazole in primary cultured rabbit gastric glands. Biochemical Pharmacology. 81(9). 1145–1151. 87 indexed citations

11.

Hori, Yasunobu, Jun Matsukawa, Toshiyuki Takeuchi, et al.. (2011). A Study Comparing the Antisecretory Effect of TAK-438, a Novel Potassium-Competitive Acid Blocker (P-CAB) With Lansoprazole in Animals. Gastroenterology. 140(5). S–577.

12.

Hori, Yasunobu, Akio Imanishi, Jun Matsukawa, et al.. (2010). 1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine Monofumarate (TAK-438), a Novel and Potent Potassium-Competitive Acid Blocker for the Treatment of Acid-Related Diseases. Journal of Pharmacology and Experimental Therapeutics. 335(1). 231–238. 164 indexed citations

13.

Nishida, Haruyuki, et al.. (1985). Experimental studies on aclacinomycin.. PubMed. 11(1). 9–15. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact